Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19 - Reuters

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi

July 2 (Reuters) - The COVID-19 vaccine developed by Ocugen Inc's (OCGN.O) Indian partner, Bharat Biotech, has been found to be 93.4% effective against severe cases of COVID-19 in a late-stage trial, the U.S. drug developer said on Friday.

Reporting by Dania Nadeem in Bengaluru; Editing by Ramakrishnan M.

Our Standards: The Thomson Reuters Trust Principles.

Adblock test (Why?)

"severe" - Google News
July 03, 2021 at 05:13AM
https://ift.tt/3Ao16vM

Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19 - Reuters
"severe" - Google News
https://ift.tt/2OrY17E
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update

Bagikan Berita Ini